Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection.

Abstract

The immunological and virological impact of short-term treatment initiated during acute human immunodeficiency virus type 1 (HIV-1) infection was assessed prospectively in 20 subjects, 12 of whom initiated highly active antiretroviral therapy (HAART) for 24 weeks and then terminated treatment. Treatment resulted in suppression of viremia, an increase in the… (More)

Topics

3 Figures and Tables

Cite this paper

@article{Streeck2006ImmunologicalAV, title={Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection.}, author={Hendrik Streeck and Heiko K Jessen and Galit Alter and Nickolas Teigen and Mike T Waring and Arne B Jessen and Ingrid Stahmer and Jan van Lunzen and Mathias Lichterfeld and Xiaojiang Gao and Todd M. Allen and Mary N Carrington and Bruce D. Walker and J{\"{u}rgen K. Rockstroh and Marcus A. Altfeld}, journal={The Journal of infectious diseases}, year={2006}, volume={194 6}, pages={734-9} }